COST-EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW

被引：1
|
作者：
Chen, W. [1 ]
Tang, Z. [2 ]
Wang, X. [2 ]
Li, J. [3 ]
Luo, Z. [3 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Bristol Myers Squibb Co, Shanghai, Peoples R China
[3] Normin Hlth Changsha Representat Off, Changsha, Hunan, Peoples R China
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.518
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN18
引用
收藏
页码：A805 / A805
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China
    Li, Runqin
    Lin, Xiao
    Wang, Jing-Yue
    Wang, Xiaomo
    Lu, Junfeng
    Liu, Yali
    Cao, Zhenhuan
    Ren, Shan
    Ma, Lina
    Jin, Yi
    Zheng, Sujun
    Hu, Zhongjie
    Wang, Li
    Chen, Xinyue
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (17)
  • [42] Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy
    Massad, E.
    Coutinho, F. A. B.
    Chaib, E.
    Burattini, M. N.
    EPIDEMIOLOGY AND INFECTION, 2009, 137 (02): : 241 - 249
  • [43] Cost and Cost-Effectiveness of the Management Strategies of Chronic Urticaria A Systematic Review
    Nochaiwong, Surapon
    Chuamanochan, Mati
    Ruengorn, Chidchanok
    Awiphan, Ratanaporn
    Bernstein, Jonathan A.
    Thavorn, Kednapa
    JAMA DERMATOLOGY, 2024, 160 (11) : 1225 - 1236
  • [44] Effectiveness, safety and cost-effectiveness of the negative pressure wound therapy on the treatment of chronic wounds: a systematic review
    Trujillo-Martin, Maria
    Garcia-Perez, Lidia
    Serrano-Aguilar, Pedro
    MEDICINA CLINICA, 2011, 137 (07): : 321 - 328
  • [45] Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and-Negative Chronic Hepatitis B
    Oyaguez, Itziar
    Buti, Maria
    Brosa, Max
    Rueda, Magdalena
    Casado, Miguel A.
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 358 - 365
  • [46] A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES OF GENE THERAPY TREATMENTS FOR HEMOPHILIA TYPE A AND B
    Alshehri, A.
    Svensson, M.
    Beckman, L.
    Dougherty, J. A.
    VALUE IN HEALTH, 2024, 27 (06) : S78 - S78
  • [47] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
    Susan JM Hahné
    Irene K Veldhuijzen
    Lucas Wiessing
    Tek-Ang Lim
    Mika Salminen
    Marita van de Laar
    BMC Infectious Diseases, 13
  • [48] Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
    Hahne, Susan J. M.
    Veldhuijzen, Irene K.
    Wiessing, Lucas
    Lim, Tek-Ang
    Salminen, Mika
    van de Laar, Marita
    BMC INFECTIOUS DISEASES, 2013, 13
  • [49] Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy
    Lui, Yanni Yan-Ni
    Tsoi, Kelvin Kam-Fai
    Wong, Vincent Wai-Sun
    Kao, Jia-Horny
    Hou, Jin-Lin
    Teo, Eng-Kiong
    Mohamed, Rosmawati
    Piratvisuth, Teerha
    Han, Kwang-Hyub
    Mihm, Ulrike
    Wong, Grace Lai-Hung
    Chan, Henry Lik-Yuen
    ANTIVIRAL THERAPY, 2010, 15 (02) : 145 - 155
  • [50] THE COST-EFFECTIVENESS OF TREATMENT FOR CHRONIC HEART FAILURE: A SYSTEMATIC REVIEW
    Webb, N.
    Cowie, M. R.
    Taylor, M.
    Briggs, A.
    Cohen, A.
    de Pouvourville, G.
    Haroun, R.
    Trueman, D.
    Deschaseaux, C.
    VALUE IN HEALTH, 2015, 18 (07) : A391 - A391
12345